PORTA, CAMILLO
 Distribuzione geografica
Continente #
NA - Nord America 3.748
EU - Europa 2.036
AS - Asia 1.939
SA - Sud America 47
AF - Africa 18
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.795
Nazione #
US - Stati Uniti d'America 3.708
CN - Cina 1.629
IE - Irlanda 1.167
FI - Finlandia 297
SG - Singapore 254
DE - Germania 163
UA - Ucraina 114
IT - Italia 92
SE - Svezia 82
CA - Canada 39
BR - Brasile 36
GB - Regno Unito 31
FR - Francia 19
JP - Giappone 14
NL - Olanda 12
MU - Mauritius 11
BE - Belgio 10
IN - India 10
CZ - Repubblica Ceca 9
RU - Federazione Russa 9
LT - Lituania 6
AT - Austria 5
TR - Turchia 5
AU - Australia 4
PE - Perù 4
AZ - Azerbaigian 3
CL - Cile 3
IL - Israele 3
IR - Iran 3
LV - Lettonia 3
AM - Armenia 2
AR - Argentina 2
BD - Bangladesh 2
BG - Bulgaria 2
CO - Colombia 2
DZ - Algeria 2
ES - Italia 2
EU - Europa 2
GR - Grecia 2
HK - Hong Kong 2
HU - Ungheria 2
IS - Islanda 2
MA - Marocco 2
MY - Malesia 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TN - Tunisia 1
VN - Vietnam 1
Totale 7.795
Città #
Dublin 1.167
Chandler 870
Nanjing 380
Beijing 336
Ashburn 319
Boardman 256
Princeton 230
Lawrence 221
Helsinki 213
Jacksonville 167
Medford 167
Wilmington 165
Nanchang 157
Singapore 132
Shanghai 103
Jiaxing 102
Shenyang 92
Changsha 91
Hebei 91
Hangzhou 89
Ann Arbor 64
New York 55
Tianjin 48
Los Angeles 42
Dearborn 39
Norwalk 36
Pavia 36
Toronto 31
Fairfield 23
Woodbridge 19
Chicago 18
Guangzhou 18
Washington 18
Falkenstein 17
Redwood City 17
Jinan 13
Piscataway 13
Ningbo 12
Zhengzhou 12
Dallas 11
Kunming 11
Brussels 10
Seattle 10
Tokyo 10
Des Moines 9
Taizhou 9
London 8
Atlanta 7
Munich 7
Brno 6
Milan 6
Verona 6
Berlin 4
Borås 4
Hyderabad 4
Lima 4
Meppel 4
Rockville 4
Sacramento 4
San Genesio Ed Uniti 4
Baku 3
Frankfurt am Main 3
Fuzhou 3
Hefei 3
Honcho 3
Naples 3
Nuremberg 3
Ottawa 3
Padova 3
Riga 3
San Francisco 3
Santa Clara 3
Serra 3
Tappahannock 3
Vienna 3
Bratislava 2
Cambridge 2
Canberra 2
Cedar Knolls 2
Chengdu 2
Groningen 2
Haikou 2
Hong Kong 2
Leawood 2
Monmouth Junction 2
Moscow 2
Newark 2
Olomouc 2
Pognana Lario 2
Pune 2
Quanzhou 2
Redmond 2
Reykjavik 2
Santiago Metropolitan 2
Shenzhen 2
Shijiazhuang 2
Sofia 2
St Petersburg 2
São Paulo 2
Tel Aviv 2
Totale 6.116
Nome #
Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study. 81
Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells. 80
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells 77
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study 77
Orai1 and Transient Receptor Potential channels as novel molecular targets to impair tumor neovascularisation in renal cell carcinoma and other malignancies 76
Alterata espressione dei canali del Ca2+ in cellule progenitrici endoteliali di pazienti affetti da carcinoma cellulare renale, mielofibrosi idiopatica e tumore della mammella 75
Antiproliferative and cytokinetic effects of the specific Akt inhibitor perifosine on different solid tumor cell lines. 74
Analysis of TERRA expression in Head and Neck Tumors. 74
Analysis of TERRA expression in Head and Neck Tumors. 73
Case report: long-lasting response in a patient with metastatic renal cell cancer receiving antitumor cytotoxic T lymphocytes 73
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 73
Allopurinol Mouthwashes In Methotrexate-induced Stomatitis 71
Autoimmunity in thrombotic thrombocytopenic purpura 70
Endoplasmic reticulum Ca2+ handling and apoptotic resistance in tumor-derived endothelial colony forming cells 68
Changes in circulating pro-angiogenic cytokines, other than VEGF, before progression to sunitinib therapy in advanced renal cell carcinoma patients. 66
Acute Kidney Injury in Cancer Patients 66
Catheter seeding of hepatocellular carcinoma following placement of a total implantable access port system 65
Cytokinetic and pro-apoptotic effects induced by inhibition of Aurora Kinases: a novel strategy for malignant mesothelioma treatment. 64
Lingual metastasis from renal cell carcinoma: a case report and literature review. 64
Ultrastructural and functional differences between normal and tumor endothelial progenitor cells 62
Breast and renal cancer—Derived endothelial colony forming cells share a common gene signature 60
[Hypokalemic rhabdomyolysis and thiazide diuretics. 3 clinical cases] 60
Circulating endothelial progenitor cells from patients with renal cell carcinoma display aberrant VEGF regulation, reduced apoptosis and altered ultrastructure 57
[Eosinophilic infiltration of the gastrointestinal system: description of a clinical case simulating a lymphoproliferative process] 57
Thrombotic Thrombocytopenic Purpura In Systemic Lupus-erythematosus 55
Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma. 55
Autoantibody Profile In Thrombotic Thrombocytopenic Purpura 54
Phenotypic and functional characterization of endothelial progenitor cells isolated from peripheral blood of renal cell carcinoma patients 54
Acute promyelocytic leukaemia (APL): chemotherapy or bone marrow transplantation? 54
Impaired bone marrow hematopoietic progenitor cell function in rheumatoid arthritis patients candidated to autologous hematopoietic stem cell transplantation 54
Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma 54
Allopurinol mouthwashes in the treatment of 5-fluorouracil-induced stomatitis 53
Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib 53
Sarcoidosis following beta-interferon therapy for multiple myeloma 52
Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis? 52
Eosinophils and C4 predict clinical failure of combination imunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patients 51
Store-operated Ca2+ entry is over-expressed in endothelial colony forming cells isolated from tumoral patients; its role in cell proliferation and tubulogenesis 51
Prognostic Value of 18 F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel 50
Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy 49
Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient 49
Ocular involvement in acute thrombotic thrombocytopenic purpura 49
Osteonecrosis of the Jaw in Patients with Metastatic Renal Cell Cancer Treated with Bisphosphonates and Targeted Agents: Results of an Italian Multicenter Study and Review of the Literature 49
Intrahepatic fluorodeoxyuridine to treat unresectable hepatocellular carcinoma patients 48
Nephrectomy As A Component of Systemic Treatment For Renal-cell Carcinoma Patients 48
Telomeric repeat-containing RNAs (TERRA) decrease in squamous cell carcinoma of the head and neck is associated with worsened clinical outcome 48
Thrombotic thrombocytopenic purpura resistant to plasma-exchange: salvage treatment with high-dose IgG or vincristine. Italian Cooperative Group for TTP 48
Cationic protein-rich supernatants of cultured eosinophils from IL-2-treated patients have no cytotoxic activity on human renal cell carcinoma and melanoma cells: A preliminary report 47
Concurrent intra-arterial carboplatin administration and radiation therapy for the tretment of advanced head and neck squamous cell carcinima: short term results. 46
Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP 46
Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Italian Cooperative Group for Thrombotic Thrombocytopenic Purpura 46
Tivantinib, a new option for second-line treatment of advanced hepatocellular carcinoma? the experience of Italian centers 46
Inhibition of Aurora kinases as a novel strategy to treat malignant mesothelioma (Mme): cytokinetic and pro-apoptotic effects.. 45
Cisplatin, mitomycin-C, 5-fluorouracil and leucovorin combination chemotherapy (l-FCM) in locally advanced unresectable or metastatic gastric carcinoma: a phase-II study 45
Clinical impact of Pancreatic metastases from renal cell carcinoma: A multicenter retrospective analysis 45
Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma 45
Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors 45
Thrombotic thrombocytopenic purpura in systemic lupus erythematosus. Italian Cooperative Group for TTP 44
Store-operated Ca2+ entry is over-expressed in endothelial colony forming cells isolated from patients suffering of Renal Cellular Carcinoma. 44
5-methyltetrahydrofolate or 5-formyltetrahydrofolic acid to modulate 5-fluorouracil's cytotoxic activity in vivo. A phase II study in patients with advanced colon cancer 44
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy 44
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib 44
Doxorubicin/methotrexate/fluorouracil in advanced pancreatic cancer 44
Hypocholesterolemia and acute myeloid leukemia (AML) 43
Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP 43
Apoptosis and cell cycle status of hematopoietic progenitor cells in patients with severe refractory rheumatoid arthritis candidates to autografting 42
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma 42
Anti-HCV antibodies and hepatocellular carcinoma. Relationship in a medium-risk population 42
Verapamil inhibits to different extents agonist-induced Ca2+ transients in human tumor cells and in vitro tumor cell growth 42
Atrial septal aneurysm in a patient with pseudoxanthoma elasticum 42
Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. The Italian Cooperative Group for TTP 42
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma 42
[Current approaches to the first-line treatment of clear-cell renal cell carcinoma] 42
Renal effects of targeted anticancer therapies 41
Culture in embryonic kidney serum and xeno-free media as renal cell carcinoma and renal cell carcinoma cancer stem cells research model 41
Amifostine (WR-2721, Ethyol(TM)) can protect human endothelial but not tumor cells from cisplatin-induced cytotoxicity 41
Plasma and urinary endothelin-1 titers and plasma von Willebrand activity in Pseudoxanthoma elasticum 40
Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas 40
5-Fluorouracil combined with the pure L-stereoisomer of leukovorin calcium to treat advanced colon-cancer patients - a phase-ii study 40
Colon cancer in pregnancy: report of a case and review of the literature 40
Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects 40
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis 40
Editorial Comment from Dr Porta et al. to Patterns of care among patients receiving sequential targeted therapies for advanced renal cell carcinoma: A retrospective chart review in the USA 39
Intrapleural interleukin-2 induces nitric oxide production in pleural effusions from malignant mesothelioma: a possible mechanism of interleukin-2-mediated cytotoxicity? 39
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: A new pharmacodynamic marker? 39
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents 39
Algorithms in the first-line treatment of metastatic clear cell renal cell carcinoma—analysis using diagnostic nodes 39
Chronic Epstein-Barr virus infection 39
Impaired bone marrow hematopoietic progenitor cell function in rheumatoid arthritis patients candidated to autologous hematopoietic stem cell transplantation 38
Oxidative stress reduces transintestinal transports and (Na(+), K(+))-ATPase activity in rat jejunum. 38
[The infusion of high-dose immunoglobulins in a case of idiopathic thrombocytopenic purpura] 38
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: The RAINBOW analysis 38
Corrigendum to Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: The RAINBOW analysis [Ann Oncol 26, 2015 2107-2113] (doi: 10.1093/annonc/mdv315)] 38
Targeted therapy for renal cell carcinoma: Focus on 2nd and 3rd line 38
The adjuvant treatment of kidney cancer: a multidisciplinary outlook 38
Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma. 37
Store-operated Ca2+ entry is remodelled and controls in vitro angiogenesis in endothelial progenitor cells isolated from tumoral patients 37
Nitrite/nitrate balance during photoinduced cerebral ischemia in the rat determined by high-performance liquid chromatography with UV and electrochemical detection 37
Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients 37
Rebuttal to: The usefulness of compression ultrasonography of the lower limbs in patients with a clinical suspicion of pulmonary embolism 37
Low doses of alpha 2B interferon in the treatment of hairy cell leukemia: results of treatment and mean follow-up at 18 months in 13 patients 37
Totale 5.020
Categoria #
all - tutte 49.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.225


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020446 0 0 0 0 0 0 0 73 13 150 200 10
2020/2021323 29 15 12 20 7 35 11 96 14 41 29 14
2021/2022836 9 2 35 8 18 11 8 56 47 23 152 467
2022/20232.824 363 212 47 175 187 236 1 134 1.350 15 72 32
2023/20241.019 136 189 36 60 92 286 16 58 7 40 59 40
2024/2025913 88 250 102 62 41 132 77 161 0 0 0 0
Totale 8.074